Personalis (NASDAQ: PSNL) revenue
Personalis reported revenue of $69.6m for fiscal 2025, 17.7% less than in fiscal 2024 ($84.6m). Since fiscal 2018 its revenue has grown by 84.4%, an average growth of 9.1% a year.
Personalis's best year of the last 8 was fiscal 2021. The biggest drop was in fiscal 2022, −23.9%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $69.6m | −17.7% | −$88.1m | −126.4% |
| 2024 | $84.6m | +15.2% | −$68.3m | −80.7% |
| 2023 | $73.5m | +13.0% | −$109.9m | −149.6% |
| 2022 | $65.0m | −23.9% | −$115.5m | −177.6% |
| 2021 | $85.5m | +8.7% | −$65.4m | −76.4% |
| 2020 | $78.6m | +20.6% | −$42.1m | −53.6% |
| 2019 | $65.2m | +72.6% | −$22.4m | −34.4% |
| 2018 | $37.8m | — | −$13.8m | −36.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Personalis revenue compared with its sector
By revenue for its latest fiscal year, Personalis ranks 314th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Personalis, −17.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 312th | Codexis | $70.4m | 18.6% |
| 313th | Black Diamond Therapeutics | $70.0m | — |
| 314th | Personalis | $69.6m | −17.7% |
| 315th | Vir Biotechnology | $68.6m | −7.6% |
| 316th | Intellia Therapeutics | $67.7m | 16.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Personalis
- How much revenue did Personalis make in fiscal 2025?
- Personalis reported revenue of $69.6m for fiscal 2025, compared with $84.6m in fiscal 2024.
- How much has the revenue of Personalis grown?
- Between fiscal 2018 and fiscal 2025 it went from $37.8m to $69.6m: 84.4% more, an average growth of 9.1% a year.
- What was the best year for revenue at Personalis?
- Of its last 8 fiscal years, fiscal 2021, with $85.5m.
- Where does Personalis rank in its sector by revenue?
- It ranks 314th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Personalis come from?
- From the annual report (Form 10-K) that Personalis files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Personalis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Personalis: the Personalis page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.